(EN) Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca
EMERGE 402 (JZP712-402)
NCT04894591
 Actif en recrutement
|
CIUSSS DU SAGUENAY – LAC-SAINT-JEAN
 HOPITAL DE CHICOUTIMI
|
|
Pascale Duchesne
418-541-1000 poste 2840
|
(EN) A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination With Irinotecan Versus Investigator's Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer Patients
LAGOON
NCT05153239
Actif en recrutement
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
|
Marilyn Tessier
450-466-5000 poste 7691
|
(EN) A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination With Irinotecan Versus Investigator's Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer Patients
LAGOON
NCT05153239
Actif en recrutement
|
HOPITAL DE LA CITE-DE-LA-SANTE
|
|
Imane Benmouhoub
450-668-1010 poste 23671
|
Groupe d'étude en oncologie du Québec